References
- Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008;372:1107–1119.
- Gautier C, Charpin D. Environmental triggers and avoidance in the management of asthma. J Asthma Allergy 2017;10:46–56.
- Global Initiative for Asthma. Global strategy for asthma management and prevention. 2016. Available from: www.ginasthma.org
- Piątkowska E, Rusiecka-Ziółkowska J. Influence of essential oils on infectious agents. Adv Clin Exp Med 2016;25:989–995.
- Ulugbek B, Nurmatov UB, Tagiyeva N, Semple S, Devereux G, Sheikh A. Volatile organic compounds and risk of asthma and allergy: a systematic review. Eur Respir Rev 2015;24:92–101.
- Karrasch S, Linde K, Rücker G, Sommer H, Karsch-Völk M, Kleijnen J, Jörres RA, Schneider A. Accuracy of FeNO for diagnosing asthma: a systematic review. Thorax 2017;72:109–116.
- American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912–930.
- Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Report Working Party Standardization pf lung functiontests. European Community for steel and coal; Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;6:5–40.
- Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effect of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122–126.
- Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323–327.
- Jia CE, Zhang HP, Lv Y, Liang R, Jiang YQ, Powell H, Fu JJ, et al. The asthma control test and Asthma Control Questionnaire for assessing asthma control: a systematic review and meta-analysis. J Allergy Clin Immunol 2013;131:695–703.
- Hwang G, Yoon C, Choi J. A case-control study: exposure assessment of VOCs and formaldehyde for asthma in children. Aerosol Air Qual Res 2011;11:908–914.
- Lehmann I, Rehwagen M, Diez U, Seiffart A, Rolle-Kampczyk U, Richter M, Wetzig H, et al. Enhanced in vivo IgE production and T cell polarization toward the type 2 phenotype in association with indoor exposure to VOC: results of the LARS study. Int J Hyg Environ Health 2001;204:211–221.
- Sandrini A, Taylor DR, Thomas PS, Yates DH. Fractional exhaled nitric oxide in asthma: an update. Respirology 2010;15:57–70.
- Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91–95.
- Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol 2003;111:799–804.
- Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Szmitkowski M. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients. J Investig Allergol Clin Immunol 2006;16:239–246.
- Van den TLM, Prins JB, Overbeek SE, Hoogsteden HC, de Jong-ste JC. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162:953–957.
- Belda J, Giner J, Casan P, Sanchis J. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up. Chest 2001;119:1011–1017.
- Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006;129:1492–1499.
- Volbeda F, Broekema M, Lodewijk ME, Hylkema MN, Reddel H, Timens W, Postma DS, ten Hacken NHT. Clinical control of asthma associates with measures of airway inflammation. Thorax 2013;68:19–24.
- Ueno-Iio T, Shibakura M, Yokota K, Aoe M, Hyoda T, Shinohata R, Kanehiro A, et al. Lavender essential oil inhalation suppresses allergic inflammation and mucus cell hyperplasia in a murine model of asthma. Life Sci 2014;108:109–115.
- Kfoury M, Borgie M, Verdin A, Ledoux F, Courcot D, Auezova L, Fourmentin S. Essential oil components decrease pulmonary and hepatic cells inflammation induced by air pollution particulate matter. Environ Chem Lett 2016;14:345–351.